• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全甲状腺切除术作为甲状腺疾病的主要外科治疗方法:来自欠发达地区5559例甲状腺切除术的手术治疗经验

Total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region.

作者信息

Hu Jisheng, Zhao Nan, Kong Rui, Wang Dawei, Sun Bei, Wu Lifeng

机构信息

Department of Pancreatic and Biliary Surgery, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, 150001, Heilongjiang Province, China.

Department of Respiratory Medicine, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, 150001, Heilongjiang Province, China.

出版信息

World J Surg Oncol. 2016 Jan 22;14(1):20. doi: 10.1186/s12957-016-0772-1.

DOI:10.1186/s12957-016-0772-1
PMID:26801233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4722660/
Abstract

BACKGROUND

The objective of this study was to evaluate the safety of total thyroidectomy for thyroid disorders and summarise the treatment experience in a less-developed region.

METHODS

This was a retrospective observational cohort study using the computerised database of the First Affiliated Hospital of Harbin Medical University. All consecutive thyroidectomy patients from 2003 to 2014 were included in this study. Demographics, surgical procedure, diagnoses, morbidity and mortality were retrospectively reviewed.

RESULTS

There were a total of 714 men and 4845 women in this study, with a mean age of 55 (range 9-87) years. A total of 4632 patients underwent total thyroidectomy for primary surgical treatment, and 189 patients previously underwent partial thyroidectomy. A total of 56.2% of the patients had multinodular goitre, including 12.23% who were thyrotoxic. Graves' disease and Hashimoto's disease were diagnosed in 2.82 and 7.23% of the patients, respectively. Papillary thyroid cancer was identified in 1336 patients, 44.99% of whom had papillary microcarcinoma. The total prevalence of permanent complications of first-time and secondary surgeries was 0.35 and 7.41%, respectively. During thyroid surgery, 945 patients underwent parathyroid autotransplantation.

CONCLUSIONS

Initial total thyroidectomy can be safely performed for both benign and malignant thyroid diseases in a less-developed region. The morbidity of a secondary surgical procedure after subtotal thyroidectomy is significantly high compared to first-time surgery.

摘要

背景

本研究的目的是评估甲状腺疾病全甲状腺切除术的安全性,并总结在欠发达地区的治疗经验。

方法

这是一项回顾性观察队列研究,使用哈尔滨医科大学附属第一医院的计算机数据库。纳入了2003年至2014年所有连续接受甲状腺切除术的患者。对人口统计学、手术过程、诊断、发病率和死亡率进行回顾性分析。

结果

本研究共有714名男性和4845名女性,平均年龄为55岁(范围9 - 87岁)。共有4632例患者接受全甲状腺切除术作为初次手术治疗,189例患者此前接受过部分甲状腺切除术。共有56.2%的患者患有结节性甲状腺肿,其中12.23%为甲状腺毒症。分别有2.82%和7.23%的患者被诊断为格雷夫斯病和桥本氏病。1336例患者被确诊为甲状腺乳头状癌,其中44.99%为甲状腺微小癌。初次手术和二次手术永久性并发症的总发生率分别为0.35%和7.41%。在甲状腺手术期间,945例患者接受了甲状旁腺自体移植。

结论

在欠发达地区,对于良性和恶性甲状腺疾病均可安全地进行初次全甲状腺切除术。与初次手术相比,甲状腺次全切除术后二次手术的发病率明显较高。

相似文献

1
Total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region.全甲状腺切除术作为甲状腺疾病的主要外科治疗方法:来自欠发达地区5559例甲状腺切除术的手术治疗经验
World J Surg Oncol. 2016 Jan 22;14(1):20. doi: 10.1186/s12957-016-0772-1.
2
Occult thyroid carcinoma in our experience -- should we reconsider total thyroidectomy for benign thyroid pathology?我们经验中的隐匿性甲状腺癌——对于良性甲状腺病变,我们是否应重新考虑行全甲状腺切除术?
Chirurgia (Bucur). 2014 Mar-Apr;109(2):191-7.
3
Robotic thyroidectomy for benign thyroid diseases: a stepwise strategy to the adoption of robotic thyroidectomy (gasless, transaxillary approach).机器人甲状腺切除术治疗良性甲状腺疾病:采用机器人甲状腺切除术(免气腹、经腋窝入路)的分步策略
Surg Laparosc Endosc Percutan Tech. 2013 Jun;23(3):312-5. doi: 10.1097/SLE.0b013e31828b8b20.
4
Total thyroidectomy for clinically benign disease of the thyroid gland.因甲状腺临床良性疾病行甲状腺全切除术。
Br J Surg. 2004 May;91(5):569-74. doi: 10.1002/bjs.4507.
5
Total thyroidectomy: safe and adequate treatment for papillary microcarcinoma of the thyroid gland.全甲状腺切除术:甲状腺微小乳头状癌的安全且充分的治疗方法。
B-ENT. 2016 Aug;12(2):119-124.
6
Safety of total thyroidectomy.全甲状腺切除术的安全性。
ANZ J Surg. 2007 Jan-Feb;77(1-2):15-9. doi: 10.1111/j.1445-2197.2006.03897.x.
7
Surgical management of hyperthyroidism.甲状腺功能亢进症的手术治疗
Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Apr;132(2):63-6. doi: 10.1016/j.anorl.2014.04.005. Epub 2015 Jan 12.
8
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.经单侧耳后入路机器人辅助全甲状腺切除术并改良根治性颈清扫术
Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17.
9
Thyroid Surgery in Children: Clinical Outcomes.儿童甲状腺手术:临床结果
Eur J Pediatr Surg. 2015 Oct;25(5):425-9. doi: 10.1055/s-0034-1384649. Epub 2014 Aug 21.
10
Body weight change is unpredictable after total thyroidectomy.全甲状腺切除术后体重变化难以预测。
ANZ J Surg. 2018 Mar;88(3):162-166. doi: 10.1111/ans.14421. Epub 2018 Feb 14.

引用本文的文献

1
Hyperthyroidism with a normal cervical thyroid gland: A rare case report of thyroid hormone releasing mass in the chest.甲状腺正常的甲状腺功能亢进症:胸部甲状腺激素释放肿物的罕见病例报告
Int J Surg Case Rep. 2025 Jul;132:111496. doi: 10.1016/j.ijscr.2025.111496. Epub 2025 Jun 9.
2
Unilateral right thyroid swelling with contralateral left mediastinal mass of benign ectopic thyroid tissue: a rare case report.单侧右甲状腺肿大伴对侧左纵隔良性异位甲状腺组织肿块:一例罕见病例报告
Ann Med Surg (Lond). 2025 Apr 4;87(5):2982-2986. doi: 10.1097/MS9.0000000000002993. eCollection 2025 May.
3
The mammalian acid chitinase promotes oncogenic properties of thyroid cancer cells through the JAK2/STAT3 pathway.哺乳动物酸性几丁质酶通过JAK2/STAT3信号通路促进甲状腺癌细胞的致癌特性。
Eur Thyroid J. 2025 Apr 25;14(2). doi: 10.1530/ETJ-24-0311. Print 2025 Apr 1.
4
Thyroidectomy and Its Complications: A Comprehensive Analysis.甲状腺切除术及其并发症:综合分析
Biomedicines. 2025 Feb 11;13(2):433. doi: 10.3390/biomedicines13020433.
5
Celastrol promotes apoptotic cell death in thyroid cancer cells through a caspases-dependent pathway.雷公藤红素通过半胱天冬酶依赖性途径促进甲状腺癌细胞的凋亡性细胞死亡。
Thyroid Res. 2025 Feb 26;18(1):9. doi: 10.1186/s13044-024-00222-7.
6
Postoperative complications and long-term outcomes after total and subtotal thyroidectomy: a retrospective study.全甲状腺切除术和次全甲状腺切除术后的术后并发症及长期预后:一项回顾性研究
Sci Rep. 2025 Jan 29;15(1):3705. doi: 10.1038/s41598-024-79860-8.
7
The clinicopathological landscape of thyroid cancer in South Africa-A multi-institutional review.南非甲状腺癌的临床病理概况——一项多机构综述
World J Surg. 2024 Dec;48(12):2863-2870. doi: 10.1002/wjs.12353. Epub 2024 Sep 22.
8
Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression.Circ_0003747 通过海绵吸附 miR-338-3p 来上调 PLCD3 表达,促进甲状腺癌进展。
Epigenetics. 2023 Dec;18(1):2210339. doi: 10.1080/15592294.2023.2210339.
9
A Meta-Analysis of Risk Factors for Transient and Permanent Hypocalcemia After Total Thyroidectomy.全甲状腺切除术后短暂性和永久性低钙血症危险因素的Meta分析
Front Oncol. 2021 Feb 24;10:614089. doi: 10.3389/fonc.2020.614089. eCollection 2020.
10
The prevalence of hypocalcemia following total thyroidectomy. A retrospective study based at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.全甲状腺切除术后低钙血症的发生率。基于沙特阿拉伯吉达阿卜杜勒阿齐兹国王大学医院的回顾性研究。
Saudi Med J. 2020 Apr;41(4):431-434. doi: 10.15537/smj.2020.4.25045.

本文引用的文献

1
Effects of increased iodine intake on thyroid disorders.碘摄入增加对甲状腺疾病的影响。
Endocrinol Metab (Seoul). 2014 Sep;29(3):240-7. doi: 10.3803/EnM.2014.29.3.240.
2
Hashimoto thyroiditis: clinical and diagnostic criteria.桥本甲状腺炎:临床和诊断标准。
Autoimmun Rev. 2014 Apr-May;13(4-5):391-7. doi: 10.1016/j.autrev.2014.01.007. Epub 2014 Jan 13.
3
What do we leave behind after neartotal and subtotal thyroidectomy: just the tissue or the disease?甲状腺近全切除术和甲状腺次全切除术后我们留下了什么:仅仅是组织还是疾病?
Int J Clin Exp Med. 2013 Oct 25;6(10):922-9. eCollection 2013.
4
Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours.甲状腺癌:过度的影像学检查增加了低风险肿瘤的检出率和治疗率。
BMJ. 2013 Aug 27;347:f4706. doi: 10.1136/bmj.f4706.
5
Controversies in primary treatment of low-risk papillary thyroid cancer.低危型甲状腺乳头状癌的初级治疗争议。
Lancet. 2013 Mar 23;381(9871):1046-57. doi: 10.1016/S0140-6736(12)62205-3. Epub 2013 Mar 22.
6
Total thyroidectomy vs bilateral subtotal thyroidectomy in patients with Graves' diseases: a meta-analysis of randomized clinical trials.全甲状腺切除术与双侧甲状腺次全切除术治疗格雷夫斯病患者的疗效比较:一项随机临床试验的荟萃分析。
Clin Endocrinol (Oxf). 2013 Nov;79(5):739-46. doi: 10.1111/cen.12209. Epub 2013 Apr 19.
7
Does thyroid surgery for Graves' disease improve health-related quality of life?格雷夫斯病的甲状腺手术是否能提高健康相关生活质量?
Surg Today. 2013 Dec;43(12):1398-405. doi: 10.1007/s00595-012-0442-z. Epub 2012 Dec 11.
8
Coexistence of papillary thyroid cancer with Hashimoto thyroiditis.甲状腺乳头状癌合并桥本甲状腺炎。
Langenbecks Arch Surg. 2013 Mar;398(3):389-94. doi: 10.1007/s00423-012-1021-x. Epub 2012 Oct 26.
9
Calcium management after thyroidectomy: a simple and cost-effective method.甲状腺切除术后的钙管理:一种简单且具有成本效益的方法。
Otolaryngol Head Neck Surg. 2012 Mar;146(3):362-5. doi: 10.1177/0194599811433557. Epub 2012 Jan 11.
10
Total thyroidectomy for benign thyroid disease: is it really worthwhile?良性甲状腺疾病行甲状腺全切除术:真的值得吗?
Ann Surg. 2011 Nov;254(5):724-29; discussion 729-30. doi: 10.1097/SLA.0b013e3182360118.